$714 Million is the total value of Rhenman & Partners Asset Management AB's 85 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 16.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $29,620,000 | +5.6% | 1,000,000 | +29.0% | 4.15% | +35.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $27,364,000 | -21.9% | 115,000 | -28.1% | 3.83% | -0.2% |
| ABBV | Buy | ABBVIE INC | $25,143,000 | +35.2% | 330,000 | +57.1% | 3.52% | +72.8% |
| NVCR | Buy | NOVOCURE LTD | $24,242,000 | -17.8% | 360,000 | +2.9% | 3.40% | +5.1% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $19,950,000 | +17.0% | 80,000 | +37.9% | 2.80% | +49.5% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $19,509,000 | -10.6% | 350,000 | +2.9% | 2.73% | +14.3% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $19,189,000 | -19.2% | 1,075,000 | -2.3% | 2.69% | +3.3% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $18,691,000 | -52.5% | 592,798 | -10.2% | 2.62% | -39.3% |
| CI | Buy | CIGNA CORP NEW | $18,604,000 | -4.2% | 105,000 | +10.5% | 2.61% | +22.4% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $18,436,000 | -9.7% | 565,000 | +25.1% | 2.58% | +15.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $15,619,000 | -12.0% | 184,845 | -12.0% | 2.19% | +12.4% |
| CVS | Buy | CVS HEALTH CORP | $15,426,000 | +48.1% | 260,000 | +85.4% | 2.16% | +89.4% |
| ANTM | Buy | ANTHEM INC | $14,758,000 | -21.2% | 65,000 | +4.8% | 2.07% | +0.7% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $14,366,000 | -6.0% | 160,000 | +13.2% | 2.01% | +20.2% |
| HUM | Sell | HUMANA INC | $14,131,000 | -42.5% | 45,000 | -32.8% | 1.98% | -26.4% |
| LLY | Sell | LILLY ELI & CO | $13,872,000 | -5.3% | 100,000 | -10.3% | 1.94% | +21.1% |
| ABT | Sell | ABBOTT LABS | $13,415,000 | -25.6% | 170,000 | -18.1% | 1.88% | -4.9% |
| ABMD | Buy | ABIOMED INC | $12,774,000 | -13.9% | 88,000 | +1.1% | 1.79% | +10.1% |
| MRK | Buy | MERCK & CO INC | $12,695,000 | -12.8% | 165,000 | +3.1% | 1.78% | +11.5% |
| GH | Buy | GUARDANT HEALTH INC | $12,180,000 | +0.4% | 175,000 | +12.7% | 1.71% | +28.3% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $11,969,000 | -20.5% | 120,000 | +19.0% | 1.68% | +1.7% |
| AXNX | Buy | AXONICS MODULATION TECH INC | $11,816,000 | +29.2% | 465,000 | +40.9% | 1.66% | +65.2% |
| MDT | Buy | MEDTRONIC PLC | $11,794,000 | -16.9% | 130,780 | +4.6% | 1.65% | +6.3% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $11,390,000 | +60.6% | 23,000 | +91.7% | 1.60% | +105.4% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $11,252,000 | -12.8% | 130,000 | +8.3% | 1.58% | +11.5% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $10,926,000 | -16.9% | 365,000 | -23.2% | 1.53% | +6.2% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $10,751,000 | +21.3% | 57,000 | +50.0% | 1.51% | +55.1% |
| CNC | Buy | CENTENE CORP DEL | $10,397,000 | +18.1% | 175,000 | +25.0% | 1.46% | +51.0% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $10,080,000 | +0.9% | 240,000 | +9.1% | 1.41% | +28.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $9,993,000 | -38.0% | 130,000 | +4.0% | 1.40% | -20.7% |
| SGEN | Sell | SEATTLE GENETICS INC | $9,807,000 | -28.5% | 85,000 | -29.2% | 1.37% | -8.6% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $9,720,000 | -42.5% | 720,000 | +2.9% | 1.36% | -26.5% |
| XNCR | Sell | XENCOR INC | $8,974,000 | -15.8% | 300,325 | -3.1% | 1.26% | +7.6% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $8,723,000 | -49.2% | 567,534 | +13.5% | 1.22% | -35.0% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $8,708,000 | +24.5% | 80,000 | +31.8% | 1.22% | +59.3% |
| FGEN | Sell | FIBROGEN INC | $8,688,000 | -26.3% | 250,000 | -9.1% | 1.22% | -5.9% |
| LIVN | Sell | LIVANOVA PLC | $8,598,000 | -43.0% | 190,000 | -5.0% | 1.20% | -27.1% |
| MYOK | Sell | MYOKARDIA INC | $8,438,000 | -44.9% | 180,000 | -14.3% | 1.18% | -29.5% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $8,086,000 | – | 80,000 | +100.0% | 1.13% | – |
| HCA | Buy | HCA HEALTHCARE INC | $8,087,000 | -21.8% | 90,000 | +28.6% | 1.13% | -0.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $7,953,000 | -46.3% | 590,000 | -15.7% | 1.11% | -31.4% |
| BIIB | Buy | BIOGEN INC | $7,910,000 | +33.3% | 25,000 | +25.0% | 1.11% | +70.5% |
| COO | Buy | COOPER COS INC | $6,616,000 | +3.0% | 24,000 | +20.0% | 0.93% | +31.7% |
| XLRN | Sell | ACCELERON PHARMA INC | $6,291,000 | +18.7% | 70,000 | -30.0% | 0.88% | +51.6% |
| EXAS | Sell | EXACT SCIENCES CORP | $6,049,000 | -38.9% | 104,300 | -2.5% | 0.85% | -21.9% |
| MGNX | Sell | MACROGENICS INC | $5,820,000 | -49.5% | 1,000,000 | -5.7% | 0.82% | -35.5% |
| ALKS | Buy | ALKERMES PLC | $5,754,000 | -23.8% | 399,000 | +7.8% | 0.81% | -2.5% |
| OMCL | Sell | OMNICELL INC | $5,646,000 | -27.3% | 86,095 | -9.4% | 0.79% | -7.1% |
| SILK | Sell | SILK ROAD MEDICAL INC | $5,509,000 | -34.8% | 175,000 | -16.4% | 0.77% | -16.7% |
| EPZM | Sell | EPIZYME INC | $5,429,000 | -48.1% | 350,000 | -17.6% | 0.76% | -33.6% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $5,388,000 | – | 19,000 | +100.0% | 0.76% | – |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $5,374,000 | -28.2% | 550,000 | -15.4% | 0.75% | -8.3% |
| GKOS | Sell | GLAUKOS CORP | $5,092,000 | -60.2% | 165,000 | -29.8% | 0.71% | -49.2% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $4,764,000 | -30.0% | 140,000 | +12.0% | 0.67% | -10.6% |
| SGMO | SANGAMO THERAPEUTICS INC | $4,459,000 | -23.9% | 700,000 | 0.0% | 0.62% | -2.6% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $3,903,000 | -48.9% | 110,000 | -31.2% | 0.55% | -34.6% |
| RDUS | Buy | RADIUS HEALTH INC | $3,835,000 | +11.9% | 295,000 | +73.5% | 0.54% | +42.8% |
| INCY | Sell | INCYTE CORP | $3,662,000 | -35.5% | 50,000 | -23.1% | 0.51% | -17.5% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $3,530,000 | -42.9% | 1,000,000 | -7.4% | 0.50% | -26.9% |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $3,310,000 | -13.6% | 246,307 | +28.8% | 0.46% | +10.5% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $3,302,000 | -6.0% | 121,400 | -31.8% | 0.46% | +20.3% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $3,256,000 | -19.8% | 220,000 | -12.0% | 0.46% | +2.5% |
| BDX | Sell | BECTON DICKINSON & CO | $3,217,000 | -65.2% | 14,000 | -58.8% | 0.45% | -55.5% |
| STML | Sell | STEMLINE THERAPEUTICS INC | $3,146,000 | -61.1% | 650,000 | -14.5% | 0.44% | -50.2% |
| QURE | Buy | UNIQURE NV | $3,122,000 | -27.4% | 65,798 | +9.7% | 0.44% | -7.2% |
| BLUE | Buy | BLUEBIRD BIO INC | $3,079,000 | -38.4% | 67,000 | +17.5% | 0.43% | -21.4% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INC | $3,045,000 | – | 68,524 | +100.0% | 0.43% | – |
| GTHX | Sell | G1 THERAPEUTICS INC | $2,757,000 | -60.4% | 250,172 | -5.0% | 0.39% | -49.4% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $2,708,000 | -33.4% | 1,736,176 | -8.6% | 0.38% | -15.0% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $2,679,000 | +9.3% | 100,000 | +25.0% | 0.38% | +39.9% |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $2,518,000 | -49.2% | 40,000 | 0.0% | 0.35% | -35.0% | |
| BGNE | BEIGENE LTDsponsored adr | $2,462,000 | -25.7% | 20,000 | 0.0% | 0.34% | -5.0% | |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $2,379,000 | -52.6% | 165,000 | +10.0% | 0.33% | -39.5% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $2,200,000 | -74.3% | 550,000 | +37.5% | 0.31% | -67.2% |
| VRAY | Buy | VIEWRAY INC | $2,125,000 | -32.9% | 850,000 | +13.3% | 0.30% | -14.1% |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $1,995,000 | -39.0% | 950,000 | -5.0% | 0.28% | -22.1% |
| SAGE | SAGE THERAPEUTICS INC | $1,436,000 | -60.2% | 50,000 | 0.0% | 0.20% | -49.2% | |
| CLLS | CELLECTIS S Asponsored ads | $1,330,000 | -46.3% | 144,604 | 0.0% | 0.19% | -31.4% | |
| VKTX | VIKING THERAPEUTICS INC | $936,000 | -41.6% | 200,000 | 0.0% | 0.13% | -25.6% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $684,000 | -37.0% | 300,000 | 0.0% | 0.10% | -19.3% | |
| IBM | INTERNATIONAL BUSINESS MACHS | $246,000 | -17.2% | 2,215 | 0.0% | 0.03% | +3.0% | |
| CVX | CHEVRON CORP | $215,000 | -39.9% | 2,974 | 0.0% | 0.03% | -23.1% | |
| XOM | Buy | EXXON MOBIL CORP | $205,000 | -23.8% | 5,388 | +39.8% | 0.03% | 0.0% |
| JHG | JANUS HENDERSON GROUP PLC | $163,000 | -37.3% | 10,645 | 0.0% | 0.02% | -17.9% | |
| F | FORD MTR CO DEL | $141,000 | -48.0% | 29,164 | 0.0% | 0.02% | -33.3% | |
| HAL | Exit | HALLIBURTON CO | $0 | – | -8,299 | -100.0% | -0.02% | – |
| GOOGL | Exit | ALPHABET INCcap stk cl a | $0 | – | -160 | -100.0% | -0.02% | – |
| NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -8,761 | -100.0% | -0.02% | – |
| BUD | Exit | ANHEUSER-BUSCH INBEV SA/NVsponsored adr | $0 | – | -2,806 | -100.0% | -0.02% | – |
| WFC | Exit | WELLS FARGO CO NEW | $0 | – | -5,272 | -100.0% | -0.03% | – |
| JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -2,095 | -100.0% | -0.03% | – |
| QCOM | Exit | QUALCOMM INC | $0 | – | -3,391 | -100.0% | -0.03% | – |
| DIS | Exit | DISNEY WALT CO | $0 | – | -2,083 | -100.0% | -0.03% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -75,000 | -100.0% | -0.34% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -140,000 | -100.0% | -0.43% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -27,000 | -100.0% | -1.11% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -800,000 | -100.0% | -1.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-04-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.